Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Mono Pharmacare Ltd

NSE: MONOPHARMA · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹8.40
Market cap
₹14.84 Cr
Revenue (annual)
₹165.7 Cr
Net profit (annual)
₹0.73 Cr
P/E (TTM)
20.3×Sector 47.3×
Promoter holding
56.72%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:08 IST NSE
Management Change

Mono Pharmacare Management Change

Mr. Rahul Joshi resigned as Company Secretary and Compliance Officer effective July 1, 2026. The resignation cited pending salary dues and non-payment of salary.

18:01 IST NSE
Management Change

Mono Pharmacare Management Change

Mono Pharmacare Limited has received consent from Ms. Nirmala Ranawat for her appointment as an Independent Director. Her professional background includes extensive corporate law and taxation experience.

11:57 IST NSE
Management Change

Mono Pharmacare Management Change

Mono Pharmacare Limited announced the resignation of its Internal Auditor, M/s. Kaliya & Associates, effective May 4, 2026. The change was disclosed as a routine regulatory filing regarding Key Managerial Personnel/Auditors and does not involve any stated financial impact.

19:30 IST NSE
Management Change

Mono Pharmacare Management Change

M/s. Kaliya & Associates has resigned as the Internal Auditor of Mono Pharmacare Limited effective May 5, 2026. The resignation is attributed to inordinate delays in the finalization of accounts for FY 2025-26, which prevented the auditors from performing their duties in accordance with professional standards and independence requirements.